TDF Drugs by Gilead

If you or a family member developed bone or kidney toxicity after taking Gilead’s TDF drugs for the treatment or prevention of HIV or for PrEP (Pre-Exposure Prophylaxis), you may be entitled to significant legal compensation. After suffering debilitating physical and financial harm from a prescription medication that was deceptively marketed, litigation is one of the most effective ways to obtain fair compensation and hold Big Pharma responsible.

HIV Litigation Attorneys™ are leaders in TDF litigation and are committed to bringing TDF drug manufacturer Gilead to justice. Allegations raised in personal injury lawsuits filed against Gilead argue there is evidence that Gilead executives knew as early as 2000 that its blockbuster HIV medications marketed under the names of Viread, Truvada, Stribild and others could permanently damage the kidneys and bones, and that Gilead failed to sufficiently disclose those potential side effects to patients.

TDF HIV Medications at the Center of Litigation

Plaintiffs have alleged that Gilead concealed TDF drug risks and intentionally stalled the release of a safer version of the HIV medication (TAF), so that it could continue reaping profits at the expense of public health. Our law firm is spearheading litigation against Gilead and was the first law firm to bring these types of cases in the entire country.

We encourage you to reach out for a confidential case review with HIV Litigation Attorneys™. You may be entitled to monetary damages for the side effects suffered from taking Tenofovir (TDF) drugs including:

  • Truvada (tenofovir disoproxil fumarate and emtricitabine)
  • Viread (tenofovir disoproxil fumarate, TDF)
  • Atripla(efavirenz, emtricitabine and tenofovir disoproxil fumarate)
  • Complera (emtricitabine, rilpivirine, and tenofovir disoproxil fumarate)
  • Stribild (elvitegravir, cobicistat, emtricitabine, tenofovir disoproxil fumarate)

Our talented attorneys are well-versed in mass tort and class action product liability litigation and have the resources, expertise and determination to secure the most favorable outcomes for clients.

TDF Drug Dangers

Tenofovir disoproxil fumarate, more commonly known as TDF, was approved by the FDA in October 2001 for the treatment of HIV-1 infection in adults. Tenofovir was utilized as a front-line retroviral treatment after it was discovered to fight HIV by Gilead scientists in Europe in the late 1990s. TDF was later combined with other retroviral agents and marketed under different trade names like Truvada – one of the top-selling HIV medications worldwide. 

It is alleged that Gilead misrepresented the risks of TDF and failed to provide the medical community and patients with vital information about detrimental side effects including chronic kidney disease, renal failure, bone demineralization, and other adverse health conditions.

According to court documents, research has demonstrated that TDF, which is administered in high doses for maximum efficacy, is linked to both bone and renal toxicity. In one study involving Truvada, researchers found that bone mineral density declined by 2 to 6 percent in patients within the first two years of treatment. A separate study out of the University of California discovered that Truvada exposure increases the risk for abnormal protein levels in urine, declining kidney function and possible renal failure. A recent lawsuit filed by a California man who took the HIV medication Truvada for 10 years alleges he was diagnosed with a rare kidney disorder known as Fanconi syndrome, as well as osteopenia and osteoporosis as a result of Gilead’s negligent marketing practices.

TDF drugs reap over $11 billion in yearly sales for Gilead. Plaintiffs contend Gilead should be held accountable for withholding the significant dangers of its HIV drug simply to boost profits.

About Gilead Sciences

Gilead Sciences, Inc. was established in 1987 and is headquartered in Foster City, California. Over the past three decades, the company has grown to become one of the world’s largest biopharmaceutical companies, employing some 11,000 people across six continents. Gilead’s portfolio of pharmaceutical products includes medications for HIV/AIDS, inflammatory and respiratory diseases, cancer, cardiovascular conditions and liver diseases.

Gilead has long been a heavyweight in the antiretroviral drug market, with HIV medications accounting for some 50 percent of the company’s total annual revenue. Gilead is currently facing a wave of lawsuits arising from its TDF drugs.

A consumer class action and individual personal injury lawsuits have been filed against Gilead in California State Court and federal courts in Louisiana and Washington D.C. regarding the company’s alleged misrepresentations of its TDF drugs and its suppression of a less toxic version in order to prolong the TDF patent life.

HIV Litigation Attorneys™ can help those who were harmed by Viread, Truvada, Atripla, Complera or Stribild protect their rights and hold negligent drug makers accountable for their transgressions. Whether you suffered bone fractures, kidney disease, osteopenia, liver damage or renal failure, you may have a viable claim for damages against Gilead.

FDA Admonishes Gilead for Marketing Practices

While Gilead delayed rolling out the safer Tenofovir Alafenamide (TAF) until 2015, millions of patients with HIV needlessly suffered the adverse effects caused by TDF drugs. FDA regulators issued two warning letters to Gilead regarding its marketing practices of TDF medicines. According to a 2002 warning, Gilead’s salespeople were instructed to say that TDF was ‘extremely safe’ and had no known toxicities. A year later, the agency issued a second warning letter which required that Gilead comply with the Federal Food, Drug, and Cosmetic Act, 21 U.S.C. 352 by providing accurate information about the significant side effects connected with TDF. 

TAKE ACTION

HIV Litigation Attorneys™: Protect Your Rights

Gilead has enjoyed enormous profit margins on tenofovir-based drugs, but at the considerable expense of millions of innocent people. HIV Litigation Attorneys™ are leading the charge against Gilead, delivering client-focused representation. A successful lawsuit can secure necessary compensation for medical expenses, lost income, pain, suffering, and the wrongful death of a loved one.

Legal actions are time- sensitive and subject to strict statutes of limitation, so do not hesitate if you think you may have a claim. To explore your legal options, we invite you to schedule a complimentary, no-obligation case review.

Additional Resources:

  1. AIDS Healthcare Foundation, AHF Files Petition for Review of Gilead AIDS Drug Patent Case with U.S. Supreme Court https://www.aidshealth.org/2018/08/ahf-files-petition-for-review-of-gilead-aids-drug-patent-case-with-u-s-supreme-court/
  2. Los Angeles Times, Patients sue Gilead, saying drug company intentionally delayed safer HIV medicine https://www.latimes.com/business/la-fi-gilead-hiv-drug-lawsuit-20180509-story.html
  3. US Court of Appeals for the Federal Court, AIDS HEALTHCARE FOUNDATION, INC., Plaintiff-Appellant v. GILEAD SCIENCES, INC., JAPAN TOBACCO INC., Defendants-Appellees JOHNSON & JOHNSON, JANSSEN SCIENCES IRELAND UC, http://www.cafc.uscourts.gov/sites/default/files/opinions-orders/16-2475.Opinion.5-10-2018.1.PDF
  4. US Department of Health and Human Services – AIDS info, Truvada https://aidsinfo.nih.gov/drugs/406/truvada/0/patient
  5. FDA, Antiretroviral drugs used in the treatment of HIV infection https://www.fda.gov/forpatients/illness/hivaids/treatment/ucm118915.htm